# PANDORA: Paravertebral AdjuNctive DexamethasOne Palmitate Reducing Chronic Pain After Caridiac Surgery

> **NCT05920967** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 562 (actual)

## Conditions studied

- Chronic Postoperative Pain

## Interventions

- **DRUG:** Dexamethasone Palmitate
- **DRUG:** Dexamethasone Sodium Phosphate

## Key facts

- **NCT ID:** NCT05920967
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-11
- **Primary completion:** 2024-09-18
- **Final completion:** 2025-12-30
- **Target enrollment:** 562 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05920967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05920967, "PANDORA: Paravertebral AdjuNctive DexamethasOne Palmitate Reducing Chronic Pain After Caridiac Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05920967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*